In the BioHarmony Drug Report Database

"Preview" Icon

Eptacog alfa (activated)

NovoSeven (eptacog alfa (activated)) is a protein pharmaceutical. Eptacog alfa (activated) was first approved as NovoSeven on 1996-02-23. It has been approved in Europe to treat factor VII deficiency, hemophilia a, hemophilia b, and thrombasthenia.

 

Trade Name

 

NovoSeven
 

Common Name

 

eptacog alfa (activated)
 

ChEMBL ID

 

CHEMBL2108334
 

Indication

 

factor vii deficiency, hemophilia a, hemophilia b, thrombasthenia
 

Drug Class

 

Image (chem structure or protein)

Eptacog alfa (activated) structure rendering